Volteface

We are an advocacy and communications organisation. Our content platform cultivates fresh thinking and new ideas to reduce drug related harm.

[Volteface @VoltefaceHub]

Breaking: @lyphedispensary has launched the V range to UK patients.

Find out more about what that means for patients and the sector below 👇

https://t.co/5et9UqIkWT

[Volteface @VoltefaceHub]

Breaking: @lyphedispensary has launched the V range to UK patients.

Find out more about what that means for patients and the sector below 👇

https://t.co/5et9UqIkWT

[Paul North @Paul__North]

Nice milestone for the new business - our first commercial filming job for the @UKCanCouncil at @Fieldfisher Law Firm.

Cracking event - speakers were spot on and enjoyed recording tons of vox pops with Holly.

[Medical Cannabis Project UK @MedCanProject]

Our research findings and policy recommendations highlighted in this article by @VoltefaceHub on the “hidden harms” faced by cannabis patients

[Volteface @VoltefaceHub]

Kamala Harris has taken a bold step, endorsing full cannabis legalisation.

She emphasised the need to stop criminalising cannabis use, particularly for marginalised communities disproportionately affected by drug laws.

Read more:

https://t.co/Ld5RBM1RkI

[Volteface @VoltefaceHub]

5/ The study calls for education, reform, and better access to NHS prescriptions to reduce inequality.

Full article and breakdown here:

https://t.co/QvKFokDzQ7

[Volteface @VoltefaceHub]

🧵1/ Cannabis has been legal for medical use in the UK since 2018, but patients still face stigma. A new study explores how prohibitionist attitudes persist. 👇

https://t.co/QvKFokDzQ7

[Volteface @VoltefaceHub]

4/ Social stigma forces patients to hide their use or justify it as "medical," perpetuating the divide between recreational and medical users.

[Volteface @VoltefaceHub]

8/ The rise in ketamine use demands action, not panic. Let’s ensure young people are empowered with the knowledge and support they need to make safer decisions. #DrugEducation #HarmReduction #Ketamine
https://t.co/raZz09Iu5u

[Volteface @VoltefaceHub]

🧵 Is Ketamine Use Among Young People in the UK a Growing Crisis?

1/ Recent data shows an increase in ketamine use among young people, but is it a crisis or a moderate rise? Let's dive into the stats and health impacts of this dissociative drug.

https://t.co/raZz09Iu5u

[Volteface @VoltefaceHub]

7/ Schools, universities, and harm reduction services must offer up-to-date, evidence-based education on ketamine’s risks, focusing on safer use and treatment options. Prevention starts with awareness! 🧠

[Volteface @VoltefaceHub]

🔄 Industry Impact: These updates bring CBPMs in line with other unlicensed medicines. While improving quality, they may cause short-term disruptions for businesses and patients alike. #CannabisIndustry

(6/6)

Read here: https://t.co/FttRq2zSLx

[Volteface @VoltefaceHub]

🚫 Communication Restrictions: Companies are prohibited from directly communicating with patients about products. Instead, all communication must go through clinicians or pharmacists. #PatientSafety

(5/6)